Search

everythinglearnresearchcommunity

for

Search:↓

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

These new skin treatments are safer and more effective with minimal side effects.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Cancer treatments often cause skin, nail, and hair problems.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Baricitinib is a promising treatment for alopecia areata in the UAE, but there are challenges with data and access.

Baicalin nanocapsules greatly enhance its anticancer effects on breast cancer cells.

Targeting lipid metabolism can help treat advanced, resistant cancers.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Baricitinib is effective and safe for treating alopecia areata in Korea.

Topical Minoxidil effectively and safely regrows hair in cancer patients.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Tedisamil and glibenclamide affect cromakalim and minoxidil sulphate differently in rat aorta.

Minoxidil helps hair growth in people with monilethrix without side effects.

Previous alopecia areata treatments do not affect the long-term effectiveness of ritlecitinib.

Patients and doctors often agree on the severity of eyebrow and eyelash hair loss in severe alopecia areata.